David B Clifford MD

PubMed

• Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.
  Nicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, Marine Joly, Maria Del Carmen Garcia Martearena
  Brain. 2026-06-18
• 1 citations
  Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.
  Nora Möhn, Lea Grote-Levi, Agnes Bonifacius, Sabine Tischer-Zimmermann, Sandra Nay
  JAMA Neurology. 2026-03-01
• 1 citations
  Treating Alzheimer's disease in a person living with HIV.
  David B Clifford, Tammie L S Benzinger, Jee-Young Han, Savannah Powles, Madeline Paczynski
  Alzheimer's & Dementia. 2026-02-17

Journal Articles

• Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome  
  Giacomini PS, Rosenberg A, Metz I, Araujo D, Arbour N, Bar-Or A for the Maraviroc in Multiple Sclerosis-Associated PML-IRIS (MIMSAPI) Group, N Engl J Med, 1/1/2014
• Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder  
  Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA, Clinical Infectious Diseases, 1/1/2014
• Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV antiretroviral therapy effects resear...  
  Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB, the CHARTER Group, Journal of HIV/AIDS & Social Services, 1/1/2014

Books/Book Chapters

• Global HIV/AIDS Medicine 
  Chapter: Primary neurological manifestation of HIV/AIDS. 
  Page 261 - 269Clifford DB, Mitike MTEditors: Volberding PA, Sande MA, Lange J, Greene WC.Saunders Elsevier2008
• Handbook of Dementing Illnesses 
  Chapter: HIV-associated dementia. 
  Page 321 - 331Clifford DB, Gould MEditors: Morris JC, Galvin JE, Holtzman DM.Taylor and Francis Group, New York, NYEdition 2nd,2006
• Neurological Therapeutics Principles and Practice 
  Chapter: Neurological complications of HIV infection. 
  Page 1060 - 1073Clifford DBEditors: Biller J, Cairncross JG, Dyck PJ, Edmeads JG, Engel AG, Fahn S, Ford B, Gilliam FG, Heilman KM, Noseworthy JH, Patterson MC, Roos KL, Samuels MA, Sharpe JA, Wijdicks EFM.Informa Healthcare, LondonEdition 2nd,2006

Abstracts/Posters

• MBL2 promoter polymorphism rs7096206 predicts brain metabolite anomalies in HIV-infected adults.
  Singh KK, Deng Q, Fennema-Notestine C, Vaida F, Ellis RJ, Letendre S, Franklin D, Rosario D, Corkran S, Gelman BB, Clifford DB, Collier AC, Marra CM, McArthur JC, Morg..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
  Wagner GA, Franklin DR, Caballero G, Chaillon A, Kosakovsky Pond SL, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Gelman BB, Collier AC, Marra CM, Clifford DB, H..., 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014
• CSF biomarker profile in HIV patients with and without CSF viral escape.
  Perez-Valero I, Letendre S, Heaton R, Ellis R, McCutchan A, Simpson D, Deutsch R, Grant I and the CHARTER Group, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2/3/2014

Other

• Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. 
  Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N, BMC Psychiatry
  1/1/2010
• Targeting HIV therapy for the brain. 
  Clifford DB and Simpson D, HIV:Advances in Research and Therapy
  1/1/1998
• Primary neurologic complications of HIV infection. Improving the Management of HIV disease. 
  Clifford DB
  1/1/1997